Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aussie Researchers Say Work On Anti-Melanoma Vaccine Shows Promise

This article was originally published in PharmAsia News

Executive Summary

An Australian research team reports early promise in an attempt to develop a vaccine against melanoma. One of the team leaders said the work centers on developing peptides and their tumor-specific antigens as is done with traditional vaccines. But to make a cancer vaccine, he said, the immune system needs to detect tumor-specific antigens on the outside of cancer cells. The research, he said, has disclosed the team's vaccine so far is prophylactic as well as therapeutic by killing established cancer cells as it prevents others from forming. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts